Antibody Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Antibody market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.1% during the forecast period.

    This report presents the market size and development trends by detailing the Antibody market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Antibody market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Antibody industry and will help you to build a panoramic view of the industrial development.

    Antibody Market, By Type:

    • IgM

    • IgG

    • IgA

    • Other

    Antibody Market, By Application:

    • Therapeutic

    • Research

    • Diagnostic

    Some of the leading players are as follows:

    • Johnson & Johnson

    • Sanofi

    • Novartis

    • Roche

    • Amgen

    • Pfizer

    • AbbVie

    • Alexion Pharmaceuticals

    • Seattle Genetics

    • GlaxoSmithKline

    • Bristol-Myers Squibb

    • Merck

    • Biogen

    • AstraZeneca

    • Bayer

    • Lilly

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Antibody Market: Technology Type Analysis

    • 4.1 Antibody Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Antibody Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 IgM

      • 4.3.2 IgG

      • 4.3.3 IgA

      • 4.3.4 Other

    5 Antibody Market: Product Analysis

    • 5.1 Antibody Product Market Share Analysis, 2018 & 2026

    • 5.2 Antibody Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Antibody Market: Application Analysis

    • 6.1 Antibody Application Market Share Analysis, 2018 & 2026

    • 6.2 Antibody Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Therapeutic

      • 6.3.2 Research

      • 6.3.3 Diagnostic

    7 Antibody Market: Regional Analysis

    • 7.1 Antibody Regional Market Share Analysis, 2018 & 2026

    • 7.2 Antibody Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Johnson & Johnson

      • 9.1.1 Johnson & Johnson Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Sanofi

      • 9.2.1 Sanofi Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Novartis

      • 9.3.1 Novartis Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Roche

      • 9.4.1 Roche Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Amgen

      • 9.5.1 Amgen Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Pfizer

      • 9.6.1 Pfizer Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 AbbVie

      • 9.7.1 AbbVie Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Alexion Pharmaceuticals

      • 9.8.1 Alexion Pharmaceuticals Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Seattle Genetics

      • 9.9.1 Seattle Genetics Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 GlaxoSmithKline

      • 9.10.1 GlaxoSmithKline Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Bristol-Myers Squibb

      • 9.11.1 Bristol-Myers Squibb Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Merck

      • 9.12.1 Merck Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 Biogen

      • 9.13.1 Biogen Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 AstraZeneca

      • 9.14.1 AstraZeneca Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Bayer

      • 9.15.1 Bayer Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Lilly

      • 9.16.1 Lilly Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

     

    The List of Tables and Figures (Totals 109 Figures and 152 Tables)

    • Figure IgM Antibody market, 2015 - 2026 (USD Million)

    • Figure IgG Antibody market, 2015 - 2026 (USD Million)

    • Figure IgA Antibody market, 2015 - 2026 (USD Million)

    • Figure Other Antibody market, 2015 - 2026 (USD Million)

    • Figure Therapeutic market, 2015 - 2026 (USD Million)

    • Figure Research market, 2015 - 2026 (USD Million)

    • Figure Diagnostic market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Antibody market, by country, 2015 - 2026 (USD Million)

    • Table North America Antibody market, by type, 2015 - 2026 (USD Million)

    • Table North America Antibody market, by product, 2015 - 2026 (USD Million)

    • Table North America Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Antibody market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Antibody market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Canada Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Canada Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Europe Antibody market, by country, 2015 - 2026 (USD Million)

    • Table Europe Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Europe Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Europe Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Antibody market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Antibody market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Germany Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Germany Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Antibody market, by type, 2015 - 2026 (USD Million)

    • Table France Antibody market, by product, 2015 - 2026 (USD Million)

    • Table France Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Italy Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Italy Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Spain Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Spain Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Antibody market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Antibody market, by type, 2015 - 2026 (USD Million)

    • Table China Antibody market, by product, 2015 - 2026 (USD Million)

    • Table China Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Japan Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Japan Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Antibody market, by type, 2015 - 2026 (USD Million)

    • Table India Antibody market, by product, 2015 - 2026 (USD Million)

    • Table India Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Antibody market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Antibody market, by application, 2015 - 2026 (USD Million)

    • Table MEA Antibody market, by country, 2015 - 2026 (USD Million)

    • Table MEA Antibody market, by type, 2015 - 2026 (USD Million)

    • Table MEA Antibody market, by product, 2015 - 2026 (USD Million)

    • Table MEA Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Antibody market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Antibody market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Antibody market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Antibody market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Antibody market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Amgen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AbbVie Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alexion Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Seattle Genetics Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Biogen Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table AstraZeneca Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lilly Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.